Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy

Cell Metabolism(2024)10.1016/j.cmet.2024.04.013Source: DataRank Database

Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy is a research paper published in Cell Metabolism (2024). On theSindex it has a DataRank of 0. It has been cited 47 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access47 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 8.03)OA: hybridTopics (39)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Arjun Singh ORCID,Aditya Ganju ORCID,Todd A. Lydic ORCID,Louis C. Glazer,Richard Kolesnick ORCID

Live enrichment

PubMed:38718792 PMC:PMC11222062 OpenAlex:https://openalex.org/W4396691553

National Cancer Institute

Grant: P30 CA008748

NIH

Grant: R01EY016077

NIH

Grant: R01EY030766

NEI NIH HHS

Grant: R01 EY025383

NEI NIH HHS

Grant: R01 EY028049

FWCI

8.03

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc

journalhttps://doi.org/10.1016/j.cmet.2024.04.013

publisherhttps://doi.org/10.1016/j.cmet.2024.04.013

publisherhttps://api.elsevier.com/content/article/PII:S1550413124001335?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1550413124001335?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38718792

Fields of Study

Sphingolipid Metabolism and SignalingRetinal Diseases and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

MeSH Terms

AnimalsCeramidesDiabetes Mellitus, ExperimentalDiabetic RetinopathyFemaleHumansImmunotherapyMaleMice, Inbred C57BLRetinaTumor Necrosis Factor-alphaVitreous BodyApoptosisMice, KnockoutEndothelial CellsMiceRatsInterleukin-1beta

Keywords

CeramideDiabetic retinopathyRetinopathyMedicineDiabetes mellitusCancer researchApoptosisImmunologyEndocrinologyBiologyBiochemistryRetinaTNFαIL-1βInflammationDiabetesEndothelial CellSphingomyelinase

Sustainable Development Goals

SDG 0: Zero hunger